RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00034924.xml
PDF herunterladen
Nuklearmedizin 2016; 55(06): 210-212
DOI: 10.1055/s-0037-1616508
DOI: 10.1055/s-0037-1616508
Editorial
Der hoch-normale fT4-Spiegel ist mit Vorhofflimmern assoziiert
Neue Daten ergänzen die DGN-Handlungsempfehlung zur RadioiodtherapieWeitere Informationen
Publikationsverlauf
received:
30. April 2016
accepted:
02. Mai 2016
Publikationsdatum:
09. Januar 2018 (online)
-
Literatur
- 1 Cappola AR, Arnold AM, Wulczyn K. et al. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metab 2015; 100: 1088-1096.
- 2 Cappola AR, Fried LP, Arnold AM. et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006; 295: 1033-1041.
- 3 Chaker L, Heeringa J, Dehghan A. et al. Normal thyroid function and the risk of atrial fibrillation: the Rotterdam study. J Clin Endocrinol Metab 2015; 100: 3718-3724.
- 4 Chaker L. Study links low thyroid function to greater odds of type 2 diabetes. 98th annual meeting of the Endocrine Society, Boston. www.eurekalert.org/pub_releases/2016-04 (18.04.2016)
- 5 Chen YC, Chen SA, Chen YJ. et al. Effect of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocites. J Am Coll Cardiol 2002; 39: 366-372.
- 6 Collet TH, Gussekloo J, Bauer DC. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012; 172: 799-809.
- 7 Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012; 379: 1142-1154.
- 8 Dietlein M, Grünwald F, Schmidt M. et al. Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5). Stand 10/2015 - AWMF-Registrierungsnummer 031-003. Nuklearmedizin. 2016 http://dx.doi.org/10.3413/Nukmed-0823-16-04
- 9 Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004; 59: 31-50.
- 10 Gammage MD, Parle JV, Holder RL. et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007; 167: 928-934.
- 11 Haentjens P, van Meerhaeghe A, Poppe K, Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from data cohort studies. Eur J Endocrinol 2008; 159: 320-341.
- 12 Heeringa J, Hoogendoorn EH, van der Deure WM. et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 2008; 168: 2219-2224.
- 13 Mammen JS, McGready J, Oxman R. et al. Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the Baltimore Longitudinal Study of Aging. Thyroid 2015; 25: 979-986.
- 14 Ozturk S, Dikbas O, Baltaci D. et al. Evaluation of atrial conduction abnormalities and left atrial mechanical functions in patients with subclinical thyroid disorders. Endokryn Pol 2012; 63: 286-293.
- 15 Sawin CT, Geller A, Wolf PA. et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-1252.
- 16 Selmer C, Olesen JB, Hansen ML. et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. Br Med J 2012; 345: e7895.
- 17 Sousa PA, Providencia R, Albenque JP. et al. Impact of free thyroxine on the outcome of left atrial ablation procedures. Am J Cardiol 2015; 116: 1863-1868.
- 18 Taylor PN, Razvi S, Pearce SH, Dayan CM. A review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab 2013; 98: 3562-3571.